Anti-UGT2B15 antibodies are used in the immunodetection of the protein UDP glucuronosyltransferase family 2 member B15. In humans, the canonical protein has a reported length of 530 amino acid residues and a mass of 61 kDa. Its subcellular localization is in the ER. It is reported to be expressed in many tissues. A member of the UDP-glycosyltransferase protein family, UGT2B15 is reported to be a UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include UDPGT 2B8, UDPGT2B15, UDPGTH3, UGT2B8, UDP-glucuronosyltransferase 2B15, and HLUG4. Some UGT2B15 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. ELISA, Immunofluorescence, and Immunohistochemistry are also common applications.